Chitosan, a naturally occurring polysaccharide derived from chitin, has demonstrated significant potential as an antiviral ...

A new study from researchers at Weill Cornell Medicine-Qatar (WCM-Q) reveals how the SARS-CoV-2 virus evolved from initially ...

The study explores the potential of chitosan derivatives as novel inhibitors against the wild-type and emerging variants of ...

In the COVID-19 pandemic era, at-home, portable tests were crucial for knowing when to wear a mask or isolate at home. Now, ...

Non-active site mutations such as L50F are crucial for restoring the viral fitness of SARS-CoV-2 main protease. Here, the authors use full-length Mpro protein as substrate and demonstrate that ...

The following is a summary of “Plasma Lipopolysaccharide-Binding Protein (LBP) Is Induced in Critically Ill Females with Gram ...

Researchers found that COVID-19 may accelerate biological processes linked to Alzheimer’s, showing changes in brain-related ...

Leukocyte count is an independent predictor of future postacute sequelae of severe acute respiratory coronavirus 2 infection (PASC) in postmenopausal women.

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

The first sa-mRNA vaccine to reach any market was Gennova Biopharmaceuticals' Gemcovac, which was launched in India in 2022 ...

Five years since it launched, advances powered by the National Drug Discovery Centre are helping transform medical research in Australia and fast-tracking development of new home-grown treatments.